Observation On The Prognosis Of Patients With Phlegm-blood-stasis Acute Coronary Syndrome Treated By Ditan Qingxin Decoction After PCI

Objective: In this study,self-made Fangdi Tan Qingxin Decoction was used to treat patients with phlegm-blood-stasis acute coronary syndrome after PCI,and its effectiveness and safety were observed by comparing the changes of various indicators before and after treatment for exploring new treatment methods.Methods: A retrospective study was performed on 60 patients with phlegm-bloodstasis type who received coronary interventional therapy in the Second Areas of Heart Disease,Affiliated Hospital of Shandong University of Traditional Chinese Medicine from November 2019 to December 2021,and they were divided into two groups according to random number table method,with 30 cases in the control group and 30 cases in the treatment group.Control group given routine PCI postoperative treatment acute coronary syndrome(acs),on the basis of control group and treatment group treated with polyester phlegm blessed are tonga subtraction,8 weeks after treatment,the record before and after treatment of left heart ejection fraction(LVEF),heart rate variability(HRV)related parameters of time domain and frequency domain,the number of ventricular premature beat,TCM syndrome integral,statistical processing,draw the conclusion.Results: There was no significant difference in baseline between 2 groups before treatment(P > 0.05).After 8 weeks of treatment,left cardiac ejection fraction in both groups was higher than that before treatment,and the treatment group was better than the control group,the difference was statistically significant(P < 0.05).The number of premature ventricular beats was decreased in both groups,and the treatment group was better than the control group,the difference was statistically significant(P < 0.05).The temporal indexes of heart rate variability(SDNN,SDANN,RMSSD)were improved,and the treatment group was better than the control group,the difference was statistically significant(P < 0.05).Frequency domain indicators(LF/HF)in both groups were better after treatment than before,and the treatment group was better than the control group with statistical significance(P < 0.05).The TCM syndrome score was lower after treatment than before,and the treatment group was better than the control group,the differences were statistically significant(P < 0.05).Conclusion: this retrospective study adopts polyester phlegm blessed are tonga subtraction treated with conventional western medicine treatment of PCI postoperative patients with acute coronary syndrome(acs),can significantly improve the clinical symptoms in patients with phlegm and blood stasis type,improve the body condition and the quality of life,improve the SDNN,SDANN and autonomic nervous function in patients with recovery and no adverse reaction,improve prognosis,worthy of clinical popularization and application.